Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Biotron Limited Rights Issue

Non-Renounceable Rights Issue Prospectus (November 2025)

Rounding of fractions of attaching options

Dispatch of prospectus and offer open

Appendix 2A – Application for quotation of securities

Notification of issue, conversion or payment up of unquoted equity securities

Notification of issue, conversion or payment up of unquoted equity securities

Completion of Tranche 2 of Placement

Completion of acquisition of Sedarex Limited

Appendix 3G – Notification of issue, conversion or payment up of unquoted equity securities

Appendix 2A – Application for quotation of securities

Appendix 2A – Application for quotation of securities

Appendix 2A – Application for quotation of securities

Completion of the Entitlement Offer

Successful Issue of the Entitlement Offer Shortfall

Appendix 2A – Application for quotation of securities

Supplementary Prospectus

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 11 February 2026        Legal Notices and Privacy
Cleantalk Pixel